Log in to save to my catalogue

Exploring the role of Nrf2 signaling in glioblastoma multiforme

Exploring the role of Nrf2 signaling in glioblastoma multiforme

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_62c04a0031754a42ab634b430707e4aa

Exploring the role of Nrf2 signaling in glioblastoma multiforme

About this item

Full title

Exploring the role of Nrf2 signaling in glioblastoma multiforme

Publisher

New York: Springer US

Journal title

Discover. Oncology, 2022-09, Vol.13 (1), p.94-12, Article 94

Language

English

Formats

Publication information

Publisher

New York: Springer US

More information

Scope and Contents

Contents

Glioblastoma multiforme (GBM) is one of the most aggressive glial cell tumors in adults. Although current treatment options for GBM offer some therapeutic benefit, median survival remains poor and does not generally exceed 14 months. Several genes, such as isocitrate dehydrogenase (IDH) enzyme and
O
6-methylguanine-DNA methyltransferase (MGMT...

Alternative Titles

Full title

Exploring the role of Nrf2 signaling in glioblastoma multiforme

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_62c04a0031754a42ab634b430707e4aa

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_62c04a0031754a42ab634b430707e4aa

Other Identifiers

ISSN

2730-6011

E-ISSN

2730-6011

DOI

10.1007/s12672-022-00556-4

How to access this item